What is Bristol-Myers Squibb Company's average annual return?

Since 1973, Bristol-Myers Squibb Company (BMY) has returned about 9.3% a year (the compound annual growth rate) and an average calendar-year return of 11.7%.

What were Bristol-Myers Squibb Company's best and worst years?

Over 1973–2026, the best year was 1997 (+75.3%) and the worst was 2002 (-52.4%).

How often is Bristol-Myers Squibb Company up in a year?

38 of the 53 full years since 1973 were positive — about 72% of the time.

BMY

Bristol-Myers Squibb CompanyStock · Healthcare

$58.13+$1.69 (+2.99%)as of market close, Jul 2, 2026

CompareLLYUNHJNJABBVMRKABT

BMY returns by year

Bristol-Myers Squibb Company has returned +9.3% annually (CAGR) since 1973. Calendar-year, monthly and weekly total returns for Bristol-Myers Squibb Company (BMY) below, through July 2, 2026 — the most recent year is year-to-date.

Annualized (CAGR)

+9.3%

1973–2026

Average year

+11.7%

53 full years

Best year

+75.3%

1997

Worst year

-52.4%

2002

Positive years

38/53

72% up

Bristol-Myers Squibb Company returns by year (1973–2026)#

Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return).

Bristol-Myers Squibb Company annual returns by year
Year	Start price	End price	Dividend	Total return
2026YTD	$53.94	$58.13	+2.4%	+10.1%
2025	$56.56	$53.94	+4.6%	+0.0%
2024	$51.31	$56.56	+5.5%	+15.7%
2023	$71.95	$51.31	+2.5%	-26.2%
2022	$62.35	$71.95	+3.6%	+19.0%
2021	$62.03	$62.35	+2.3%	+2.9%
2020	$64.19	$62.03	+6.8%	+3.5%
2019	$51.98	$64.19	+8.7%	+32.2%
2018	$61.28	$51.98	+4.6%	-10.6%
2017	$58.44	$61.28	+5.8%	+10.6%
2016	$68.79	$58.44	+3.1%	-11.9%
2015	$59.03	$68.79	+5.5%	+22.0%
2014	$53.15	$59.03	+6.3%	+17.4%
2013	$32.59	$53.15	+10.6%	+73.7%
2012	$35.24	$32.59	+3.7%	-3.8%
2011	$26.48	$35.24	+6.3%	+39.4%
2010	$25.25	$26.48	+3.9%	+8.7%
2009	$23.25	$25.25	+6.2%	+14.8%
2008	$26.52	$23.25	+6.3%	-6.0%
2007	$26.32	$26.52	+4.0%	+4.7%
2006	$22.98	$26.32	+5.4%	+19.9%
2005	$25.62	$22.98	+4.1%	-6.2%
2004	$28.60	$25.62	+3.1%	-7.3%
2003	$23.15	$28.60	+5.5%	+29.0%
2002	$51.00	$23.15	+2.2%	-52.4%
2001	$70.37	$51.00	+1.3%	-26.2%
2000	$61.09	$70.37	+1.8%	+17.0%
1999	$63.68	$61.09	+1.0%	-3.0%
1998	$45.03	$63.68	+0.7%	+42.1%
1997	$25.94	$45.03	+1.6%	+75.3%
1996	$20.43	$25.94	+1.2%	+28.2%
1995	$13.77	$20.43	+1.2%	+49.5%
1994	$13.86	$13.77	+1.6%	+0.9%
1993	$16.06	$13.86	+1.0%	-12.7%
1992	$21.00	$16.06	+0.6%	-23.0%
1991	$15.94	$21.00	+1.0%	+32.7%
1990	$13.32	$15.94	+1.0%	+20.7%
1989	$10.77	$13.32	+1.2%	+25.0%
1988	$9.90	$10.77	+1.3%	+10.0%
1987	$9.83	$9.90	+0.4%	+1.2%
1986	$7.88	$9.83	+0.3%	+25.0%
1985	$6.23	$7.88	+0.5%	+27.0%
1984	$5.03	$6.23	+0.5%	+24.5%
1983	$4.00	$5.03	+0.4%	+26.1%
1982	$3.16	$4.00	+0.3%	+26.9%
1981	$3.00	$3.16	+0.2%	+5.7%
1980	$2.20	$3.00	+0.3%	+36.4%
1979	$2.13	$2.20	+0.3%	+3.8%
1978	$2.00	$2.13	+0.2%	+6.5%
1977	$2.04	$2.00	+0.2%	-1.8%
1976	$2.05	$2.04	+0.1%	-0.3%
1975	$1.49	$2.05	+0.1%	+37.5%
1974	$1.38	$1.49	+0.1%	+8.2%
1973	$2.05	$1.38	+0.1%	-32.7%

Total return by period

-50%+0%+50%

'73'78'83'88'93'98'03'08'13'18'23

Methodology#

Returns are total returns (dividends reinvested), computed from BMY's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. See also the periodic table of returns. Past performance does not predict future returns; not investment advice.

See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum

FAQ

What is Bristol-Myers Squibb Company's average annual return?: Since 1973, Bristol-Myers Squibb Company (BMY) has returned about 9.3% a year (the compound annual growth rate) and an average calendar-year return of 11.7%.
What were Bristol-Myers Squibb Company's best and worst years?: Over 1973–2026, the best year was 1997 (+75.3%) and the worst was 2002 (-52.4%).
How often is Bristol-Myers Squibb Company up in a year?: 38 of the 53 full years since 1973 were positive — about 72% of the time.